Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Detailed Quantification of Glomerular Structural Lesions Associates with Clinical Outcomes and Transcriptomic Profiles in Nephrotic Syndrome

Jeffrey B. Hodgin, Laura H. Mariani, Jarcy Zee, Q Liu, Abigail R. Smith, Sean Eddy, John Hartman, Habib Hamidi, Joseph P. Gaut, Matthew B. Palmer, Cynthia C. Nast, Anthony Chang, Stephen Hewitt, Brenda W. Gillespie, Matthias Kretzler, Lawrence B. Holzman, Laura Barisoni, for the Nephrotic Syndrome Study Network (NEPTUNE)
doi: https://doi.org/10.1101/2021.09.16.21263706
Jeffrey B. Hodgin
1Renal Pathology, Department of Pathology and Internal Medicine, Division of Nephrology, University of Michigan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: laura.barisoni@duke.edu jhodgin@umich.edu
Laura H. Mariani
2Division of Nephrology, Department of Internal Medicine, University of Michigan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jarcy Zee
3Department of Biostatistics, Epidemiology, and Informatics, University of Pennsylvania, and Children’s Hospital of Philadelphia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Q Liu
4Arbor Research Collaborative for Health
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Abigail R. Smith
4Arbor Research Collaborative for Health
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sean Eddy
2Division of Nephrology, Department of Internal Medicine, University of Michigan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John Hartman
2Division of Nephrology, Department of Internal Medicine, University of Michigan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Habib Hamidi
2Division of Nephrology, Department of Internal Medicine, University of Michigan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joseph P. Gaut
5Department of Pathology and Immunology, and Internal Medicine, Washington University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Matthew B. Palmer
6Department of Pathology, University of Pennsylvania
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Cynthia C. Nast
7Department of Pathology, Cedars-Sinai Medical Center
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anthony Chang
8Department of Pathology, University of Chicago Medicine, Chicago, IL
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stephen Hewitt
9Laboratory of Pathology, National Cancer Institute, National Institutes of Health
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Brenda W. Gillespie
10Department of Biostatistics, University of Michigan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Matthias Kretzler
2Division of Nephrology, Department of Internal Medicine, University of Michigan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lawrence B. Holzman
11Renal-Electrolyte and Hypertension Division, Department of Medicine, University of Pennsylvania
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Laura Barisoni
12Department of Pathology, Division of AI & Computational Pathology; Department of Medicine, Division of Nephrology, Duke University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: laura.barisoni@duke.edu jhodgin@umich.edu
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

ABSTRACT

The current classification system for focal segmental glomerulosclerosis (FSGS) and minimal change disease (MCD) does not fully capture the complex structural changes in kidney biopsies, nor the clinical and molecular heterogeneity of these diseases. The Nephrotic Syndrome Study Network (NEPTUNE) Digital Pathology Scoring System (NDPSS) was applied to 221 NEPTUNE FSGS/MCD digital kidney biopsies for glomerular scoring using 37 descriptors. The descriptor-based glomerular profiles were used to cluster patients with similar morphologic characteristics. Glomerular descriptors and patient clusters were assessed for association with time to proteinuria remission and disease progression by using adjusted Cox models, and eGFR measures over time by using linear mixed models. Messenger RNA from glomerular tissue was used to assess differentially expressed genes (DEG) between clusters and identify genes associated with individual descriptors driving cluster membership. Three clusters were identified: X (N=56), Y (N=68), and Z (N=97). Clusters Y and Z had higher probabilities of proteinuria remission (HR [95% CI]= 1.95 [0.99, 3.85] and 3.29 [1.52, 7.13], respectively), lower hazards of disease progression 0.22 [0.08, 0.57] and 0.11 [0.03, 0.45], respectively), and greater loss of eGFR over time compared with X. Cluster X had 1920 DEGs compared to Y+Z, which reflected activation of pathways of immune response and inflammation. Six individual descriptors driving the clusters individually correlated with clinical outcomes and gene expression. The NDPSS allows for characterization of FSGS/MCD patients into clinically and biologically relevant categories and uncovers histologic parameters associated with clinical outcomes and molecular signatures not included in current classification systems.

TRANSLATIONAL STATEMENT FSGS and MCD are heterogeneous diseases that manifest with a variety of structural changes often not captured by conventional classification systems. This study shows that a detailed morphologic analysis and quantification of these changes allows for better representation of the structural abnormalities within each patient and for grouping patients with similar morphologic profiles into categories that are clinically and biologically relevant.

Competing Interest Statement

Dr. Barisoni reports grants from NIH/NIDDK, during the conduct of the study; personal fees from Moderna, personal fees from Protalix, personal fees from Sangamo, personal fees from Vertex, outside the submitted work. Dr. Hodgin reports grants from NIH/NIDDK, during the conduct of the study; personal fees from Astrazeneca, personal fees from Gilead, personal fees from Moderna, personal fees from NovoNordisc, personal fees from Eli Lilly, personal fees from Jansen, outside the submitted work. Dr. Holzman reports grants from NIH/NIDDK during the conduct of the study. Dr. Mariani reports grants from NIH/NIDDK during the conduct of the study, personal fees from Reata, Calliditas Therapeutics and Travere Therapeutics, outside the submitted work. Dr. Zee reports grants from NIH/NIDDK during the conduct of the study.

Funding Statement

This study was supported by a grant from the National Institute of Diabetes, Digestive, and Kidney Diseases to L.B., J.B.H., B.W.G., L.B.H., L.H.M., and J.Z. (NIDDK R01-DK118431). L.H.M. is supported through funding from NIH/NIDDK, K08 DK115891-01. The Nephrotic Syndrome Rare Disease Clinical Research Network III (NEPTUNE) is part of the Rare Diseases Clinical Research Network (RDCRN), which is funded by the National Institutes of Health (NIH) and led by the National Center for Advancing Translational Sciences (NCATS) through its Office of Rare Diseases Research (ORDR). NEPTUNE is funded under grant number U54DK083912 as a collaboration between NCATS and the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Additional funding and/or programmatic support for this project has also been provided by the University of Michigan, NephCure Kidney International and the Halpin Foundation. All RDCRN consortia are supported by the network Data Management and Coordinating Center (DMCC) (U2CTR002818). Funding support for the DMCC is provided by NCATS and the National Institute of Neurological Disorders and Stroke (NINDS).

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

NEPTUNE was approved (HUM00158219) by University of Michigan, Medical School Institutional Review Board.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

NEPTUNE gene expression data from microdissected biopsies are available for online interrogation at Nephroseq.org and have been deposited into GEO.

https://www.nephroseq.org/resource/login.html

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted September 22, 2021.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Detailed Quantification of Glomerular Structural Lesions Associates with Clinical Outcomes and Transcriptomic Profiles in Nephrotic Syndrome
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Detailed Quantification of Glomerular Structural Lesions Associates with Clinical Outcomes and Transcriptomic Profiles in Nephrotic Syndrome
Jeffrey B. Hodgin, Laura H. Mariani, Jarcy Zee, Q Liu, Abigail R. Smith, Sean Eddy, John Hartman, Habib Hamidi, Joseph P. Gaut, Matthew B. Palmer, Cynthia C. Nast, Anthony Chang, Stephen Hewitt, Brenda W. Gillespie, Matthias Kretzler, Lawrence B. Holzman, Laura Barisoni, for the Nephrotic Syndrome Study Network (NEPTUNE)
medRxiv 2021.09.16.21263706; doi: https://doi.org/10.1101/2021.09.16.21263706
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
Detailed Quantification of Glomerular Structural Lesions Associates with Clinical Outcomes and Transcriptomic Profiles in Nephrotic Syndrome
Jeffrey B. Hodgin, Laura H. Mariani, Jarcy Zee, Q Liu, Abigail R. Smith, Sean Eddy, John Hartman, Habib Hamidi, Joseph P. Gaut, Matthew B. Palmer, Cynthia C. Nast, Anthony Chang, Stephen Hewitt, Brenda W. Gillespie, Matthias Kretzler, Lawrence B. Holzman, Laura Barisoni, for the Nephrotic Syndrome Study Network (NEPTUNE)
medRxiv 2021.09.16.21263706; doi: https://doi.org/10.1101/2021.09.16.21263706

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Pathology
Subject Areas
All Articles
  • Addiction Medicine (216)
  • Allergy and Immunology (495)
  • Anesthesia (106)
  • Cardiovascular Medicine (1097)
  • Dentistry and Oral Medicine (196)
  • Dermatology (141)
  • Emergency Medicine (274)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (502)
  • Epidemiology (9773)
  • Forensic Medicine (5)
  • Gastroenterology (481)
  • Genetic and Genomic Medicine (2313)
  • Geriatric Medicine (223)
  • Health Economics (462)
  • Health Informatics (1562)
  • Health Policy (736)
  • Health Systems and Quality Improvement (604)
  • Hematology (238)
  • HIV/AIDS (504)
  • Infectious Diseases (except HIV/AIDS) (11650)
  • Intensive Care and Critical Care Medicine (617)
  • Medical Education (238)
  • Medical Ethics (67)
  • Nephrology (257)
  • Neurology (2144)
  • Nursing (134)
  • Nutrition (337)
  • Obstetrics and Gynecology (427)
  • Occupational and Environmental Health (518)
  • Oncology (1180)
  • Ophthalmology (364)
  • Orthopedics (128)
  • Otolaryngology (220)
  • Pain Medicine (147)
  • Palliative Medicine (50)
  • Pathology (311)
  • Pediatrics (695)
  • Pharmacology and Therapeutics (300)
  • Primary Care Research (267)
  • Psychiatry and Clinical Psychology (2182)
  • Public and Global Health (4663)
  • Radiology and Imaging (778)
  • Rehabilitation Medicine and Physical Therapy (457)
  • Respiratory Medicine (624)
  • Rheumatology (274)
  • Sexual and Reproductive Health (226)
  • Sports Medicine (210)
  • Surgery (252)
  • Toxicology (43)
  • Transplantation (120)
  • Urology (94)